Unknown

Dataset Information

0

Global Post-Market Clinical Follow-up of the Treovance Stent-Graft for Endovascular Aneurysm Repair: One-Year Results From the RATIONALE Registry.


ABSTRACT: PURPOSE::To evaluate the safety and performance of the Treovance stent-graft. METHODS::The global, multicenter RATIONALE registry ( ClinicalTrials.gov; identifier NCT03449875) prospectively enrolled 202 patients (mean age 73.0±7.8 years; 187 men) with abdominal aortic aneurysms (AAA) suitable for endovascular aneurysm repair (EVAR) using the Treovance. The composite primary safety endpoint was site-reported all-cause mortality and major morbidity. The primary efficacy outcome was clinical success. Further outcomes evaluated included technical success; stent-graft migration, patency, and integrity; endoleak; and aneurysm size changes. RESULTS::Technical success was 96% (194/202); 8 patients had unresolved type I endoleaks at the end of the procedure. There was no 30-day mortality and 1% major morbidity (1 myocardial infarction and 1 bowel ischemia). Clinical success at 1 year was confirmed in 194 (96%) patients; 6 of 8 patients had new/persistent endoleaks and 2 had aneurysm expansion without identified endoleak. A total of 8 (4%) reinterventions were required during the mean 13.7±3.1 months of follow-up (median 12.8). At 1 year, the Kaplan-Meier estimate for freedom from reintervention was 95.6% (95% CI 91.4% to 97.8%). Other estimates were 95.5% (95% CI 91.7% to 97.6%) for freedom from endoleak type I/III and 97.4% (95% CI 94.2% to 98.9%) for freedom from aneurysm expansion. Thirteen (6.4%) patients died; no death was aneurysm related. CONCLUSION::The RATIONALE registry showed favorable safety and clinical performance of the Treovance stent-graft for the treatment of infrarenal AAAs in a real-world setting.

SUBMITTER: Uberoi R 

PROVIDER: S-EPMC6238168 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Global Post-Market Clinical Follow-up of the Treovance Stent-Graft for Endovascular Aneurysm Repair: One-Year Results From the RATIONALE Registry.

Uberoi Raman R   Setacci Carlo C   Lescan Mario M   Lorido Antonio A   Murray David D   Szeberin Zoltán Z   Zubilewicz Tomasz T   Riambau Vincent V   Chartrungsan Angsu A   Tessarek Jörg J  

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20181003 6


<h4>Purpose:</h4>To evaluate the safety and performance of the Treovance stent-graft.<h4>Methods:</h4>The global, multicenter RATIONALE registry ( ClinicalTrials.gov; identifier NCT03449875) prospectively enrolled 202 patients (mean age 73.0±7.8 years; 187 men) with abdominal aortic aneurysms (AAA) suitable for endovascular aneurysm repair (EVAR) using the Treovance. The composite primary safety endpoint was site-reported all-cause mortality and major morbidity. The primary efficacy outcome was  ...[more]

Similar Datasets

| S-EPMC6828830 | biostudies-literature
| S-EPMC5056233 | biostudies-literature
| S-EPMC6614706 | biostudies-literature
| S-EPMC4336929 | biostudies-literature
| S-EPMC7078903 | biostudies-literature
| S-EPMC4684921 | biostudies-literature
| S-EPMC5565842 | biostudies-other
| S-EPMC7371721 | biostudies-literature
| S-EPMC7676711 | biostudies-literature